Published in Contrib Microbiol Immunol on January 01, 1991
Role of Yersinia enterocolitica Yst toxin in experimental infection of young rabbits. Infect Immun (1992) 1.16
Sources of sporadic Yersinia enterocolitica infections in Norway: a prospective case-control study. Epidemiol Infect (1994) 1.10
Evaluation of a single procedure allowing the isolation of enteropathogenic Yersinia along with other bacterial enteropathogens from human stools. PLoS One (2012) 0.89
KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab. Ann Oncol (2007) 5.68
Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis (1987) 5.48
Specific detection of methicillin-resistant Staphylococcus species by multiplex PCR. J Clin Microbiol (1995) 4.44
In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother (1978) 4.29
In vitro activity and human pharmacokinetics of teicoplanin. Antimicrob Agents Chemother (1984) 3.66
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae. Antimicrob Agents Chemother (1980) 3.61
Serogrouping of Clostridium difficile strains by slide agglutination. J Clin Microbiol (1985) 3.06
Revised biogrouping scheme of Yersinia enterocolitica. Contrib Microbiol Immunol (1987) 3.06
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrob Agents Chemother (1981) 3.05
Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. Antimicrob Agents Chemother (1978) 2.95
Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect (1997) 2.95
Pyrazinamidase activity in Yersinia enterocolitica and related organisms. J Clin Microbiol (1985) 2.83
Airport malaria in Belgium. Lancet (1982) 2.70
[Supplement to the antigenic schema of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1972) 2.52
Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax (1966) 2.42
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood. Am Rev Respir Dis (1968) 2.20
Yersinia enterocolitica infections and pork: the missing link. Lancet (1987) 2.15
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin. Antimicrob Agents Chemother (1982) 2.06
Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother (1974) 2.04
Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob Agents Chemother (1994) 1.89
In vitro activity of LY146032, a new lipopeptide antibiotic, against gram-positive cocci. Antimicrob Agents Chemother (1987) 1.86
[Somatic and flagellar antigens of Yersinia enterocolitica]. Ann Inst Pasteur (Paris) (1971) 1.82
Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams. J Antimicrob Chemother (2003) 1.73
Population genetic studies in the Congo. I. Glucose-6-phosphate dehydrogenase deficiency, hemoglobin S, and malaria. Am J Hum Genet (1966) 1.72
Mycobacteria, skins, and needles. Lancet (1969) 1.70
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species. J Clin Microbiol (2010) 1.69
Nucleotide sequence of yst, the Yersinia enterocolitica gene encoding the heat-stable enterotoxin, and prevalence of the gene among pathogenic and nonpathogenic yersiniae. Infect Immun (1990) 1.68
Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int J Syst Evol Microbiol (2001) 1.67
Plasmid characterisation in the investigation of an epidemic caused by multiply resistant Shigella dysenteriae type 1 in Central Africa. Lancet (1981) 1.65
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect (2006) 1.65
Community-acquired bacteraemia in African children. Lancet (1987) 1.61
Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli. Antimicrob Agents Chemother (1981) 1.61
Comparison of the antibacterial activity of nine cephalosporins against Enterobacteriaceae and nonfermentative gram-negative bacilli. Antimicrob Agents Chemother (1976) 1.59
HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology (1999) 1.56
Frequent isolation of Edwardsiella tarda and Pleisiomonas shigelloides from healthy Zairese freshwater fish: a possible source of sporadic diarrhea in the tropics. Appl Environ Microbiol (1980) 1.55
Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans. Report of a case with a review of the literature. J Clin Pathol (1977) 1.55
Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J Clin Microbiol (1995) 1.55
Nonvalue of cold enrichment of stools for isolation of Yersinia enterocolitica serotypes 3 and 9 from patients. J Clin Microbiol (1980) 1.54
Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J Clin Microbiol (1998) 1.53
Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatry (1999) 1.49
Isolations of Leclercia adecarboxylata from a patient with a chronically inflamed gallbladder and from a patient with sepsis without focus. J Clin Microbiol (2001) 1.44
Cryptosporidium spp., a frequent cause of diarrhea in Central Africa. J Clin Microbiol (1984) 1.44
Yersinia enterocolitica in donor blood: a case report and review. J Clin Microbiol (1989) 1.44
Triple crossover study on absorption and excretion of ampicillin, talampicillin, and amoxycillin. Antimicrob Agents Chemother (1976) 1.44
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. J Antimicrob Chemother (1998) 1.43
The novel epidemic strain O139 is closely related to the pandemic strain O1 of Vibrio cholerae. J Infect Dis (1994) 1.43
[Injuries missed in diagnosing severely injured accident victims in the emergency room]. Ned Tijdschr Geneeskd (1999) 1.42
A simple adult-mouse test for tissue invasiveness in Yersinia enterocolitica strains of low experimental virulence. J Med Microbiol (1985) 1.41
Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther (1989) 1.39
Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. Crit Care Med (1997) 1.39
Antifungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses (1989) 1.38
Isolation of Yersinia enterocolitica serotype 0: 3 from captive monkeys and domestic pigs in Zaire. Ann Soc Belg Med Trop (1978) 1.37
[Isolation of Yersinia enterocolitica by a routine coproculture technic]. Ann Inst Pasteur (Paris) (1968) 1.36
[A simple method for detecting glutamic acid decarboxylase in gram negative bacteria (author's transl)]. Ann Microbiol (Paris) (1975) 1.36
In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1981) 1.36
Rifampin and ethambutol in the retreatment of advanced pulmonary tuberculosis. Am Rev Respir Dis (1968) 1.36
In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J Pharmacol Exp Ther (1986) 1.36
Isolation of Arthrobacter spp. from clinical specimens and description of Arthrobacter cumminsii sp. nov. and Arthrobacter woluwensis sp. nov. J Clin Microbiol (1996) 1.33
Comparative pharmacokinetics of ceftazidime and moxalactam. Antimicrob Agents Chemother (1982) 1.33
AIDS and cryptococcosis (Zaire, 1977) Lancet (1983) 1.32
Yersinia enterocolitica: its isolation by cold enrichment from patients and healthy subjects. J Clin Pathol (1981) 1.31
Prevalence of fluoroquinolone resistance in Europe. Study Group 'Bacterial Resistance' of the Paul-Ehrlich-Society for Chemotherapy e. V. Infection (1994) 1.31
Fatal leishmaniasis in renal-transplant patient. Lancet (1979) 1.30
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourin Med (1986) 1.29
Comparison of the activities of the new ureidopenicillins piperacillin, mezlocillin, azlocillin, and Bay k 4999 against gram-negative organisms. Antimicrob Agents Chemother (1979) 1.28
The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure. Br J Clin Pharmacol (1984) 1.27
Carriage of Yersinia enterocolitica serotype 3 by pigs as a source of human infection. Contrib Microbiol Immunol (1979) 1.27
Acquisition of trimethoprim resistance in epidemic strain of Shigella dysenteriae type 1 from Zaire. Lancet (1982) 1.26
Pseudomonas putrefaciens as a cause of infection in humans. J Clin Pathol (1975) 1.25
Semisolid selective-motility enrichment medium for isolation of salmonellae from fecal specimens. J Clin Microbiol (1984) 1.23
Capsular typing of klebsiellae by coagglutination and latex agglutination. J Clin Microbiol (1981) 1.23
Letter: Primary amoebic meningoencephalitis after swimming in stream water. Lancet (1973) 1.22
O:13a,13b, a new pathogenic serotype of Yersinia enterocolitica. J Clin Microbiol (1984) 1.19
Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res (1992) 1.19
Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob Agents Chemother (1995) 1.18
Haemorrhagic colitis and verotoxin-producing Escherichia coli O157 in Belgium. Lancet (1987) 1.17
Long-wavelength helimagnetic order and skyrmion lattice phase in Cu2OSeO3. Phys Rev Lett (2012) 1.17
Widespread occurrence of multiple drug-resistant Salmonella typhi in India. Eur J Clin Microbiol Infect Dis (1992) 1.16
An outbreak of Ochrobactrum anthropi bacteraemia in five organ transplant patients. J Hosp Infect (1994) 1.16
Epidemiological investigation of a nosocomial outbreak of multidrug-resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect (2013) 1.15
Brevibacterium paucivorans sp. nov., from human clinical specimens. Int J Syst Evol Microbiol (2001) 1.14
Infections caused by Kingella kingae: report of four cases and review. J Infect (1986) 1.13
A multidisciplinary selection model for youth soccer: the Ghent Youth Soccer Project. Br J Sports Med (2006) 1.13
Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother (1986) 1.13
New enrichment method for isolation of pathogenic Yersinia enterocolitica serogroup O:3 from pork. Appl Environ Microbiol (1988) 1.12
[Shigellosis in Kinshasa. Bacteriologic and epidemiologic data collected over an 8-year period]. Med Trop (Mars) (1973) 1.12